Our data suggests that chimeric RNAs are prevalent in breast tumors, provide a large number of novel fusions and generate immunogenic peptides that can elicit CD8+T cell responses, thus providing an expanded repertoire for development of breast cancer vaccines. Here, CD8A is linked to breast neoplasm.